E Meltzer

527 total citations
14 papers, 447 citations indexed

About

E Meltzer is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, E Meltzer has authored 14 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology and Allergy. Recurrent topics in E Meltzer's work include Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (5 papers) and Inhalation and Respiratory Drug Delivery (4 papers). E Meltzer is often cited by papers focused on Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (5 papers) and Inhalation and Respiratory Drug Delivery (4 papers). E Meltzer collaborates with scholars based in United States, Brazil and South Africa. E Meltzer's co-authors include William W. Storms, John C. Seiner, R NATHAN, R.A. Nathan, Paul H. Ratner, Jay Grossman, Craig C. Reed, Andre van As, H.Alice Orgel and Elliot F. Ellis and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and Annals of Allergy Asthma & Immunology.

In The Last Decade

E Meltzer

14 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Meltzer United States 7 359 344 155 83 65 14 447
John C. Seiner United States 6 353 1.0× 403 1.2× 157 1.0× 96 1.2× 79 1.2× 9 546
Robert J. Settipane United States 8 594 1.7× 544 1.6× 321 2.1× 56 0.7× 86 1.3× 9 658
Andrew Simmons United Kingdom 4 327 0.9× 335 1.0× 100 0.6× 64 0.8× 84 1.3× 6 422
R.A. Nathan United States 9 338 0.9× 226 0.7× 201 1.3× 58 0.7× 34 0.5× 27 400
Valentín 4 261 0.7× 285 0.8× 63 0.4× 103 1.2× 72 1.1× 19 380
Fayol France 3 262 0.7× 285 0.8× 63 0.4× 103 1.2× 73 1.1× 4 357
M T Dordal Spain 10 260 0.7× 285 0.8× 67 0.4× 29 0.3× 116 1.8× 24 416
A. Pedinoff United States 5 306 0.9× 275 0.8× 141 0.9× 68 0.8× 58 0.9× 7 348
P. Potter South Africa 3 458 1.3× 386 1.1× 115 0.7× 32 0.4× 193 3.0× 3 554
Mena Soliman Canada 10 291 0.8× 147 0.4× 115 0.7× 17 0.2× 48 0.7× 32 355

Countries citing papers authored by E Meltzer

Since Specialization
Citations

This map shows the geographic impact of E Meltzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Meltzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Meltzer more than expected).

Fields of papers citing papers by E Meltzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Meltzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Meltzer. The network helps show where E Meltzer may publish in the future.

Co-authorship network of co-authors of E Meltzer

This figure shows the co-authorship network connecting the top 25 collaborators of E Meltzer. A scholar is included among the top collaborators of E Meltzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Meltzer. E Meltzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rowe, Steven M., Daniel Dorgan, Jorge Lascano, et al.. (2021). 544: Safety and tolerability of single and repeat doses of MRT5005, an inhaled CFTR mRNA replacement therapy, in adult CF patients. Journal of Cystic Fibrosis. 20. S257–S257. 2 indexed citations
2.
Meltzer, E, Robert S. Zeiger, Peter V. Dicpinigaitis, et al.. (2019). P351 CHRONIC COUGH IN AMERICA: PREVALENCE AND PATIENT CHARACTERISTICS. Annals of Allergy Asthma & Immunology. 123(5). S54–S54. 4 indexed citations
3.
Schmidt, Olaf, Huib A.M. Kerstjens, ER Bleecker, et al.. (2014). Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate. Pneumologie. 68(S 01). 2 indexed citations
4.
Casale, Thomas B., ER Bleecker, E Meltzer, et al.. (2013). Phase III trials to investigate tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: trial design and planned statistical analyses. Data Archiving and Networked Services (DANS). 68. 377–377. 4 indexed citations
5.
Bousquet, Jean, Warner Carr, Jonine L. Bernstein, et al.. (2012). MP29-02 is effective for the symptomatic treatment of seasonal allergic rhinitis even in those with very severe disease: a meta-analysis. Allergy. 67. 336–336. 1 indexed citations
6.
Busse, William W., E Meltzer, Lyndon E. Mansfield, et al.. (2009). Efficacy and Safety of AMG 317, an IL-4Ra Antagonist, in Atopic Asthmatic Subjects: A Randomized, Double-blind, Placebo-controlled Study. Journal of Allergy and Clinical Immunology. 123(3). 732–732. 3 indexed citations
7.
NATHAN, R, E Meltzer, John C. Seiner, & William W. Storms. (1997). Prevalence of allergic rhinitis in the United States. Journal of Allergy and Clinical Immunology. 99(6). S808–S814. 232 indexed citations
8.
Meltzer, E, R.A. Nathan, John C. Seiner, & William W. Storms. (1997). Quality of life and rhinitic symptoms: Results of a nationwide survey with the SF-36 and RQLQ questionnaires. Journal of Allergy and Clinical Immunology. 99(6). S815–S819. 93 indexed citations
9.
Meltzer, E, et al.. (1992). Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma. Journal of Allergy and Clinical Immunology. 90(1). 2–11. 27 indexed citations
10.
As, Andre van, et al.. (1991). Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis.. PubMed. 67(2 Pt 1). 156–62. 48 indexed citations
11.
LaForce, Craig, Robert J. Dockhorn, Steven R. Findlay, et al.. (1991). 60 Fluticasone propionate treatment for seasonal allergic rhinitis is safe and effective in adults and adolescents. Journal of Allergy and Clinical Immunology. 87(1). 153–153. 7 indexed citations
12.
Chervinsky, Paul, Robert J. Dockhorn, Jay Grossman, et al.. (1991). 61 Fluticasone propionate once daily is as effective as beclomethasone dipropionate twice daily for perennial allergic rhinitis. Journal of Allergy and Clinical Immunology. 87(1). 154–154. 2 indexed citations
13.
Shapiro, Gail G., James P. Kemp, Richard G. DeJong, et al.. (1990). Effects of albuterol and procaterol on exercise-induced asthma.. PubMed. 65(4). 273–6. 14 indexed citations
14.
Kemp, James P., Jacob L. Pinnas, David Tinkelman, et al.. (1986). Comparison of bronchodilator responses with bitolterol mesylate solution with the use of two different nebulizer systems in asthma. Journal of Allergy and Clinical Immunology. 77(3). 509–515. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026